Grandsouth Bancorp (GRRB) 14.0000 $GRRB GrandSouth

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Grandsouth Bancorp (GRRB) 14.0000 $GRRB

GrandSouth Bancorporation Announces First Quarter Results
PR Newswire - Thu Apr 21, 7:56AM CDT
GrandSouth Bancorporation (OTCQB: GRRB), the holding company for GrandSouth Bank, reported net income for the first quarter ended March 31, 2016. Net income for the first quarter of 2016 totaled $1.51 million compared to $1.79 million for the same period in 2015. Following the amortization (accretion) and payment of preferred stock dividends, net income available to common shareholders for the quarter ended March 31, 2016 amounted to $1.45 million or $.34 per common share, diluted compared to $1.75 million or $.51 per common share, diluted for the same period of 2015. Net interest income for the three month period ended March 31, 2016 was 14.7% higher than the same period in 2015. However, non-interest expenses, including provisions made to the reserve for loan losses, grew 43% offsetting the higher revenues and resulting in lower net earnings for the period when compared with the year earlier quarter. The annualized return on average assets for the first quarter of 2016 equaled 1.37%. The annualized return on average common equity at March 31, 2016 equaled 12.7%. Loans declined by 4%, or $14 million to $355 million from $369 million at December 31, 2015. Deposits grew significantly during the first quarter to $374 million or 6% over the balance at year end of $351 million.

GrandSouth Bancorporation Announces Third Quarter 2015 Earnings
PR Newswire - Thu Oct 15, 3:45PM CDT
GrandSouth Bancorporation (OTC: GRRB), parent company for GrandSouth Bank (GrandSouth), announced earnings of $1.36 million or $.37 per common share, diluted, for the quarter ended September 30, 2015 - an increase of 28% from earnings for the third quarter ended September 30, 2014 of $1.06 million or $.30 per common share, diluted. Net income for the nine months ended September 30, 2015 equaled $4.81 million or $1.34 per common share, diluted - an increase of 52% from earnings for the nine month period ended September 30, 2014 of $3.16 million or $.91 per common share, diluted. Annualized returns on average assets and average equity for the quarter ended September 30, 2015 were 1.32% and 12.6%, respectively, compared with the quarter ended September 30, 2014 annualized returns on average assets and average equity of 1.07% and 9.20%, respectively. Annualized returns on average assets and average equity for the nine months ended September 30, 2015 were 1.60% and 15.0%, respectively, compared with the nine months ended September 30, 2014 annualized returns on average assets and average equity of 1.06% and 9.30%, respectively.

GrandSouth Announces Second Quarter 2015 Earnings
PR Newswire - Fri Jul 24, 9:59AM CDT
GrandSouth Bancorporation (OTC: GRRB), parent company for GrandSouth Bank (GrandSouth), announced earnings of $1.66 million or $.46 per common share, diluted, for the quarter ended June 30, 2015 - an increase of 61% from earnings for the second quarter ended June 30, 2014 of $1.03 million or $.30 per common share, diluted. Net income for the six months ended June 30, 2105 equaled $3.45 million or $.97 per common share, diluted - an increase of 65% from earnings for the six month period ended June 30, 2014 of $2.10 million or $.60 per common share, diluted. Annualized returns on average assets and annualized return on average common equity for the quarter ended June 30, 2015 were 1.67% and 19.1%, respectively, compared with the quarter ended June 30, 2014 returns on average assets and average equity of 1.04% and 13.7%, respectively. Returns on average assets and average equity for the six months ended June 30, 2015 were 1.75% and 20.3%, respectively, compared with the six months ended June 30, 2014 returns on average assets and average equity of 1.06% and 14.2%, respectively.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading